Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Jun;69(6):1310–1320. doi: 10.1172/JCI110571

Thyrotropin-releasing Hormone in the Pancreas and Brain of the Rat Is Regulated by Central Noradrenergic and Dopaminergic Pathways

Dennis Engler 1,2,3, David Chad 1,2,3, Ivor MD Jackson 1,2,3
PMCID: PMC370204  PMID: 6806317

Abstract

These studies have been undertaken to evaluate the role of the brain noradrenergic and dopaminergic pathways in the regulation of the secretion of thyrotropin-releasing hormone (TRH) in the central nervous system (CNS) and pancreas of the neonatal rat. When CNS stores of norepinephrine (NE) were selectively reduced by the subcutaneous administration of the dopamine-β-hydroxylase inhibitor FLA-63, TRH concentrations were significantly reduced throughout the brain. However, when CNS stores of both NE and dopamine (DA) were depleted by the subcutaneous administration of the tyrosine hydroxylase inhibitor α-methyl-ρ-tyrosine (α-MT), TRH concentrations in the brain were not significantly altered.

FLA-63 and α-MT did not significantly reduce pancreatic catecholamine concentrations, indicating that in the basal state, these agents predominantly deplete central catecholamine stores. Nevertheless, pancreatic TRH concentrations were markedly reduced by FLA-63, and this effect was significantly attenuated by the simultaneous intracerebroventricular (icv) administration of NE. In contrast to the effects of FLA-63, α-MT caused a significant increase in pancreatic TRH concentrations, and this effect was significantly lessened by icv DA. To determine whether the sympathetic nervous system might be one route by which these central effects are mediated, a chemical sympathectomy was induced with guanethidine. This treatment selectively reduced pancreatic concentrations of NE, and caused a marked increase in pancreatic TRH concentrations.

From these observations, we conclude the following: (a) within the central nervous system, both NE and DA are involved in regulating brain TRH secretion or biosynthesis, and the direction of action of these two neurotransmitters appears to be opposite; (b) pancreatic TRH secretion or biosynthesis is also controlled by the brain noradrenergic and dopaminergic systems, and the net effects of each of these pathways appears to be opposite; (c) at least one route by which impulses from the brain may travel and modulate pancreatic TRH secretion or biosynthesis is by the sympathetic nervous system.

Full text

PDF
1310

Images in this article

1316Image
on p.1316
1316Image
on p.1316

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angeletti P. U., Levi-Montalcini R. Growth inhibition of sympathetic cells by some adrenergic blocking agents (6-hydroxydopamine-mice and rats-immunosympathectomy-chemical sympathectomy-superior cervical ganglion). Proc Natl Acad Sci U S A. 1972 Jan;69(1):86–88. doi: 10.1073/pnas.69.1.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Annunziato L., Di Renzo G., Lombardi G., Scopacasa F., Schettini G., Preziosi P., Scapagnini U. The role of central noradrenergic neurons in the control of thyrotropin secretion in the rat. Endocrinology. 1977 Mar;100(3):738–744. doi: 10.1210/endo-100-3-738. [DOI] [PubMed] [Google Scholar]
  3. Bennett G. W., Edwardson J. A., Holland D., Jeffcoate S. L., White N. Release of immunoreactive luteinising hormone-releasing hormone and thyrotrophin-releasing hormone from hypothalamus. Nature. 1975 Sep 25;257(5524):323–325. doi: 10.1038/257323a0. [DOI] [PubMed] [Google Scholar]
  4. Berthoud H. R., Jeanrenaud B. Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats. Endocrinology. 1979 Jul;105(1):146–151. doi: 10.1210/endo-105-1-146. [DOI] [PubMed] [Google Scholar]
  5. Brown M. R. Thyrotropin releasing factor: a putative CNS regulator of the autonomic nervous system. Life Sci. 1981 Apr 13;28(15-16):1789–1795. doi: 10.1016/0024-3205(81)90350-7. [DOI] [PubMed] [Google Scholar]
  6. Chihara K., Arimura A., Schally A. V. Effect of intraventricular injection of dopamine, noreprinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat hypophyseal portal blood. Endocrinology. 1979 Jun;104(6):1656–1662. doi: 10.1210/endo-104-6-1656. [DOI] [PubMed] [Google Scholar]
  7. Corrodi H., Fuxe K., Hamberger B., Ljungdahl A. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor. Eur J Pharmacol. 1970 Oct;12(2):145–155. doi: 10.1016/0014-2999(70)90059-2. [DOI] [PubMed] [Google Scholar]
  8. Corrodi H., Malmfors T. The effect of nerve activity on the depletion of the adrenergic transmitter by inhibitors of noradrenaline synthesis. Acta Physiol Scand. 1966 Jul-Aug;67(3):352–357. doi: 10.1111/j.1748-1716.1966.tb03321.x. [DOI] [PubMed] [Google Scholar]
  9. Cox J. E., Powley T. L. Prior vagotomy blocks VMH obesity in pair-fed rats. Am J Physiol. 1981 May;240(5):E573–E583. doi: 10.1152/ajpendo.1981.240.5.E573. [DOI] [PubMed] [Google Scholar]
  10. Dussault J. H., Labrie F. Development of the hypothalamic-pituitary-thyroid axis in the neonatal rat. Endocrinology. 1975 Nov;97(5):1321–1324. doi: 10.1210/endo-97-5-1321. [DOI] [PubMed] [Google Scholar]
  11. Engler D., Scanlon M. F., Jackson I. M. Thyrotropin-releasing hormone in the systemic circulation of the neonatal rat is derived from the pancreas and other extraneural tissues. J Clin Invest. 1981 Mar;67(3):800–808. doi: 10.1172/JCI110097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Foord S. M., Peters J., Scanlon M. F., Rees Smith B., Hall R. Dopaminergic control of TSH secretion in isolated rat pituitary cells. FEBS Lett. 1980 Dec 1;121(2):257–259. doi: 10.1016/0014-5793(80)80356-5. [DOI] [PubMed] [Google Scholar]
  13. Frohman L. A., Bernardis L. L. Effect of hypothalamic stimulation on plasma glucose, insulin, and glucagon levels. Am J Physiol. 1971 Dec;221(6):1596–1603. doi: 10.1152/ajplegacy.1971.221.6.1596. [DOI] [PubMed] [Google Scholar]
  14. Gold R. M. Hypothalamic obesity: the myth of the ventromedial nucleus. Science. 1973 Nov 2;182(4111):488–490. doi: 10.1126/science.182.4111.488. [DOI] [PubMed] [Google Scholar]
  15. Goto Y., Carpenter R. G., Berelowitz M., Frohman L. A. Effect of ventromedial hypothalamic lesions on the secretion of somatostatin, insulin, and glucagon by the perfused rat pancreas. Metabolism. 1980 Oct;29(10):986–990. doi: 10.1016/0026-0495(80)90044-x. [DOI] [PubMed] [Google Scholar]
  16. Grimm Y., Reichlin S. Thyrotropin releasing hormone (TRH): neurotransmitter regulation of secretion by mouse hypothalamic tissue in vitro. Endocrinology. 1973 Sep;93(3):626–631. doi: 10.1210/endo-93-3-626. [DOI] [PubMed] [Google Scholar]
  17. Heath J. W., Burnstock G. Selectivity of neuronal degeneration produced by chronic guanethidine treatment. J Neurocytol. 1977 Aug;6(4):397–405. doi: 10.1007/BF01178225. [DOI] [PubMed] [Google Scholar]
  18. Hirooka Y., Hollander C. S., Suzuki S., Ferdinand P., Juan S. I. Somatostatin inhibits release of thyrotropin releasing factor from organ cultures of rat hypothalamus. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4509–4513. doi: 10.1073/pnas.75.9.4509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Holaday J. W., D'Amato R. J., Faden A. I. Thyrotropin-releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock. Science. 1981 Jul 10;213(4504):216–218. doi: 10.1126/science.6787704. [DOI] [PubMed] [Google Scholar]
  20. Horner H. C., Szabo S. Differential effect of changing central and peripheral catecholamine levels in cysteamine-induced duodenal ulcer in the rat. Life Sci. 1981 Dec 7;29(23):2437–2443. doi: 10.1016/0024-3205(81)90481-1. [DOI] [PubMed] [Google Scholar]
  21. Jackson I. M., Reichlin S. Thyrotropin-releasing hormone (TRH): distribution in hypothalamic and extrahypothalamic brain tissues of mammalian and submammalian chordates. Endocrinology. 1974 Sep;95(3):854–862. doi: 10.1210/endo-95-3-854. [DOI] [PubMed] [Google Scholar]
  22. Johnson E. M., Jr, O'Brien F., Werbitt R. Modification and characterization of the permanent sympathectomy produced by the administration of guanethidine to newborn rats. Eur J Pharmacol. 1976 May;37(1):45–54. doi: 10.1016/0014-2999(76)90006-6. [DOI] [PubMed] [Google Scholar]
  23. Kardon F., Marcus R. J., Winokur A., Utiger R. D. Thyrotropin-releasing hormone content of rat brain and hypothalamus: results of endocrine and pharmacologic treatments. Endocrinology. 1977 Jun;100(6):1604–1609. doi: 10.1210/endo-100-6-1604. [DOI] [PubMed] [Google Scholar]
  24. Koivusalo F., Leppäluoto J. High TRF immunoreactivity in purified pancreatic extracts of fetal and newborn rats. Life Sci. 1979 Apr 30;24(18):1655–1658. doi: 10.1016/0024-3205(79)90249-2. [DOI] [PubMed] [Google Scholar]
  25. Koivusalo F., Leppäluoto J., Knip M., Rajaniemi H. Presence of TRF immunoreactivity in marginal islet cells in rat pancreas. Acta Endocrinol (Copenh) 1981 Jul;97(3):398–404. doi: 10.1530/acta.0.0970398. [DOI] [PubMed] [Google Scholar]
  26. Krulich L., Giachetti A., Marchlewska-Koj A., Hefco E., Jameson H. E. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat. Endocrinology. 1977 Feb;100(2):496–505. doi: 10.1210/endo-100-2-496. [DOI] [PubMed] [Google Scholar]
  27. Loewy A. D., Neil J. J. The role of descending monoaminergic systems in central control of blood pressure. Fed Proc. 1981 Nov;40(13):2778–2785. [PubMed] [Google Scholar]
  28. Maeda K., Frohman L. A. Release of somatostatin and thyrotropin-releasing hormone from rat hypothalamic fragments in vitro. Endocrinology. 1980 Jun;106(6):1837–1842. doi: 10.1210/endo-106-6-1837. [DOI] [PubMed] [Google Scholar]
  29. Marcano de Cotte D., De Menezes C. E., Bennett G. W., Edwardson J. A. Dopamine stimulates the degradation of gonadotropin releasing hormone by rat synaptosomes. Nature. 1980 Jan 31;283(5746):487–489. doi: 10.1038/283487a0. [DOI] [PubMed] [Google Scholar]
  30. Martino E., Lernmark A., Seo H., Steiner D. F., Refetoff S. High concentration of thyrotropin-releasing hormone in pancreatic islets. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4265–4267. doi: 10.1073/pnas.75.9.4265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Martino E., Seo H., Lernmark A., Refetoff S. Ontogenetic patterns of thyrotropin-releasing hormone-like material in rat hypothalamus, pancreas, and retina: selective effect of light deprivation. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4345–4348. doi: 10.1073/pnas.77.7.4345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Maurer R. A. Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J Biol Chem. 1980 Sep 10;255(17):8092–8097. [PubMed] [Google Scholar]
  33. Montoya E., Wilber J. F., Lorincz M. Catecholaminergic control of thyrotropin secretion. J Lab Clin Med. 1979 May;93(5):887–894. [PubMed] [Google Scholar]
  34. Moore R. Y., Bloom F. E. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci. 1978;1:129–169. doi: 10.1146/annurev.ne.01.030178.001021. [DOI] [PubMed] [Google Scholar]
  35. Moore R. Y., Bloom F. E. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci. 1979;2:113–168. doi: 10.1146/annurev.ne.02.030179.000553. [DOI] [PubMed] [Google Scholar]
  36. Mueller G. P., Simpkins J., Meites J., Moore K. E. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats. Neuroendocrinology. 1976;20(2):121–135. doi: 10.1159/000122476. [DOI] [PubMed] [Google Scholar]
  37. Negro-Vilar A., Ojeda S. R., Arimura A., McCann S. M. Dopamine and norepinephrine stimulate somatostatin release by median eminence fragments in vitro. Life Sci. 1978 Oct 9;23(14):1493–1497. doi: 10.1016/0024-3205(78)90131-5. [DOI] [PubMed] [Google Scholar]
  38. Rowe J. W., Young J. B., Minaker K. L., Stevens A. L., Pallotta J., Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981 Mar;30(3):219–225. doi: 10.2337/diab.30.3.219. [DOI] [PubMed] [Google Scholar]
  39. Rowland N., Engle D. J. Hypothalamic hyperphagia prevented by prior subdiaphragmatic vagotomy: insulin hyperphagia is unaffected. Physiol Behav. 1978 Nov;21(5):685–689. doi: 10.1016/0031-9384(78)90003-3. [DOI] [PubMed] [Google Scholar]
  40. SPECTOR S., SJOERDSMA A., UDENFRIEND S. BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther. 1965 Jan;147:86–95. [PubMed] [Google Scholar]
  41. Samols E., Weir G. C. Adrenergic modulation of pancreatic A, B, and D cells alpha-Adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. J Clin Invest. 1979 Feb;63(2):230–238. doi: 10.1172/JCI109294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Schaeffer J. M., Axelrod J., Brownstein M. J. Rigional differences in dopamine-mediated release of TRH-like material from synaptosomes. Brain Res. 1977 Dec 23;138(3):571–574. doi: 10.1016/0006-8993(77)90696-5. [DOI] [PubMed] [Google Scholar]
  43. Sorenson R. L., Elde R. P., Seybold V. Effect of norepinephrine on insulin, glucagon, and somatostatin secretion in isolated perifused rat islets. Diabetes. 1979 Oct;28(10):899–904. doi: 10.2337/diab.28.10.899. [DOI] [PubMed] [Google Scholar]
  44. Spindel E. R., Pettibone D. J., Wurtman R. J. Thyrotropin-releasing hormone (TRH) content of rat striatum: modification by drugs and lesions. Brain Res. 1981 Jul 20;216(2):323–331. doi: 10.1016/0006-8993(81)90134-7. [DOI] [PubMed] [Google Scholar]
  45. Vijayan E., Krulich L., McCann S. M. Catecholaminergic regulation of TSH and growth hormone release in ovariectomized and ovariectomized, steroid-primed rats. Neuroendocrinology. 1978;26(3):174–185. doi: 10.1159/000122779. [DOI] [PubMed] [Google Scholar]
  46. Weiner R. I., Ganong W. F. Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev. 1978 Oct;58(4):905–976. doi: 10.1152/physrev.1978.58.4.905. [DOI] [PubMed] [Google Scholar]
  47. Winokur A., Kreider M. S., Dugan J., Utiger R. D. The effects of 6-hydroxydopamine on thyrotropin-releasing hormone in rat brain. Brain Res. 1978 Aug 18;152(1):203–208. doi: 10.1016/0006-8993(78)90149-x. [DOI] [PubMed] [Google Scholar]
  48. Woods S. C., Porte D., Jr Neural control of the endocrine pancreas. Physiol Rev. 1974 Jul;54(3):596–619. doi: 10.1152/physrev.1974.54.3.596. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES